1. Gabius HJ, Gabius S, Joshi SS, et al. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe? Planta Med 1994; 60: 2?7.
2. Hajto T, Hostanska K, Gabius HJ. Modulatory potency of the ?-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 1989; 49: 4803?4808.
3. Hajto T, Hostanska, Frey K, Rordorf C, Gabius HJ. Increased secretion of tumor necrosis factor ?, interleukin 1, and interleukin 6 by human mononuclear cells exposed to ?-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990; 50: 3322?3326.
4. Müller EA, Anderer FA. Synergistic action of a plant rhamno-galacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition. Cancer Res 1990; 50: 3646?3651.
5. Schultze JL, Stettin A, Berg PA. Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.). Klin Wocbenschr 1991; 69: 397?403.